Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Avadel Pharmaceuticals PLC at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 01, 2021 / 02:15PM GMT
Release Date Price: $8.64 (-3.57%)
Umer Raffat
Evercore Inc. - Analyst

Excellent. Listen, guys, thank you all for joining us. Greg, pleasure to have you here.

Questions & Answers

Umer Raffat
Evercore Inc. - Analyst

My first question to you: do you have a PDUFA date?

Greg Divis
Avadel Pharmaceuticals plc - CEO

Yes. Umer, first, thanks for the opportunity to be a part of the conference. We appreciate the chance to participate. What we've communicated to date is that the FDA informed us back in mid-October that they weren't going to be able to meet the action date of October 15th. And they, quite frankly, needed more time to complete their review and that they wouldn't finish their review in October.

So since then, we've not been provided a new action date specifically, just to answer your question directly. At this point in time, based on what we know today and the interactions we've had to date and where the review stands, we don't expect a formal action to occur that would actually result in a new PDUFA date, whether that's a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot